Research programme: indole-3-carbinol derivatives - Eurand

Drug Profile

Research programme: indole-3-carbinol derivatives - Eurand

Alternative Names: Indole-3-carbinol derivatives research programme - Eurand/University of Urbino

Latest Information Update: 13 Apr 2010

Price : $50

At a glance

  • Originator Eurand; University of Urbino
  • Class
  • Mechanism of Action Protein kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 04 May 2007 No development reported - Preclinical for Cancer in Italy (unspecified route)
  • 21 Apr 2004 Preclinical trials in Cancer in Italy (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top